Gill and associates examined the association between treatment with antipsychotics and all-cause mortality. The risk for death
was determined at 30, 60, 120, and 180 days after the initial dispensing of antipsychotic medication. New use of atypical
antipsychotics was associated with a statistically significant increase in the risk for death at 30 days compared with nonuse
in a community-dwelling cohort and a long-term care cohort. The excess risk seemed to persist to 180 days. Compared with atypical
antipsychotics, conventional antipsychotics were associated with a higher risk for death at all time points.